Ming Cheah
Director/Board Member at HotSpot Therapeutics, Inc.
Network origin in Ming Cheah first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Yale University
499
| College/University | Other Consumer Services | 499 |
Stanford University School of Medicine
27
| College/University | Other Consumer Services | 27 |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California.
17
| Subsidiary | Investment Managers | 17 |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA.
14
| Holding Company | Biotechnology | 14 |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA.
13
| Holding Company | Pharmaceuticals: Major | 13 |
Goldman Sachs Asset Management LP (Private Equity)
 Goldman Sachs Asset Management LP (Private Equity) Investment ManagersFinance Goldman Sachs Asset Management LP (Private Equity) (Goldman Sachs Asset Management) is a private equity firm founded in 1990. The firm is headquartered in New York.
13
| Subsidiary | Investment Managers | 13 |
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA.
11
| Holding Company | Pharmaceuticals: Major | 11 |
McKinsey & Company Holdings Ltd.
 McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Part of McKinsey & Co., Inc., McKinsey & Company Holdings Ltd. is a consulting firm that partners with leaders on strategy, innovating to net zero, leading with tech, and building capabilities for a sustainable, inclusive, growing future. The company is based in London, UK. The British company specializes in Consumer Packaged Goods and has conducted research, articles, and reports on the changes that matter most for the challenges and opportunities ahead. The company was founded in 2011 by Brian K. Stafford.
9
| Subsidiary | Financial Conglomerates | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ming Cheah via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Masters Business Admin Graduate Degree Masters Business Admin Doctorate Degree | |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Investment Managers | Consultant / Advisor Chief Operating Officer Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor Director of Finance/CFO Private Equity Investor Chief Executive Officer Private Equity Investor | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| GOLDMAN SACHS BDC, INC. | Investment Managers | Chief Executive Officer Chief Operating Officer Director of Finance/CFO Director of Finance/CFO | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Founder Consultant / Advisor Chief Operating Officer Private Equity Investor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Founder | |
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Goldman Sachs Middle Market Lending Corp. II
 Goldman Sachs Middle Market Lending Corp. II Financial ConglomeratesFinance Part of The Goldman Sachs Group, Inc., Goldman Sachs Middle Market Lending Corp. II provides investment services. The company is based in New York, NY. The CEOs of the company are Alex Chi, David Miller. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | |
Cajal Neuroscience, Inc.
 Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Kallyope, Inc.
 Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
| University of Illinois | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Goldman Sachs Private Middle Market Credit II LLC
 Goldman Sachs Private Middle Market Credit II LLC Financial ConglomeratesFinance Goldman Sachs Private Middle Market Credit II LLC is a development stage pooled investment fund, which engages in investment activities. Its objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt. The company was founded on December 20, 2018 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| OTONOMY | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Investment Managers | Private Equity Investor Corporate Officer/Principal Founder | |
| New York University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Foresite Labs LLC | Private Equity Investor Chief Executive Officer | ||
| Lehigh University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla Capital Management LLC is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. Formerly known as Hambrecht & Quist Capital Management LLC, the firm serves as an investment adviser for four closed-end funds – Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NEVRO CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal |
Statistics
International
| United States | 47 |
| Denmark | 3 |
| United Kingdom | 2 |
| China | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 13 |
| Finance | 13 |
| Commercial Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 539 |
| Corporate Officer/Principal | 185 |
| Independent Dir/Board Member | 102 |
| Founder | 86 |
| Private Equity Investor | 86 |
Most connected contacts
| Insiders | |
|---|---|
| Bruce Booth | 40 |
| Heather Elizabeth Preston | 34 |
| Dan Omstead | 33 |
| Michael Grey | 32 |
| Joey Mason | 31 |
| Pascale Witz | 31 |
| Karoly Nikolich | 30 |
| Emmett Cunningham | 29 |
| Henry Skinner | 29 |
| Peter Bisgaard | 28 |
| Ernesto Zedillo Ponce de León | 28 |
| Graziano Seghezzi | 26 |
| Fouad Azzam | 25 |
| Steven J. Chu | 25 |
| Peter Moldt | 25 |
- Stock Market
- Insiders
- Ming Cheah
- Company connections
